The leading skincare brand sheds light on gender biases in a heart-warming film & is funding STEM scholarships for girls across India in partnership with School EdTech major LEAD Mumbai,18th January 2022 (GNI): Why are young…
National, 17th January 2022 (GNI): ABOUT THE AWARD# startupindia is an initiative by Shri Prime minister Narendra Modi ji and DPPIIT which seeks to recognize and reward outstanding startups and ecosystem enablers that are contributing…
मुंबई, १६ जानेवारी २०२२: आँकोलॉजीवर भर असलेले व्यवस्थापित आरोग्यसुरक्षा व्यासपीठ कारकीनॉस हेल्थकेअरने तंत्रज्ञान, आरोग्यसुरक्षा आणि जैवविज्ञान क्षेत्रातील भारतातील सर्वात आघाडीच्या व्हीसी फंड्सपैकी एक असलेल्या एंडीया पार्टनर्सकडून अनामिक रकमेचा निधी उभा केला आहे. या स्टार्टअपला सध्या टाटा…
Mumbai, 14th January 2022 (GNI): In Bollywood, it is said that if the beginning is good, then the journey becomes easy, and if the journey is interesting, then the path often lead to the top. …
मुंबई, १३ जानेवारी २०२२ (GNI): आँकोलॉजीवर भर असलेले व्यवस्थापित आरोग्यसुरक्षा व्यासपीठ कारकीनॉस हेल्थकेअरने तंत्रज्ञान, आरोग्यसुरक्षा आणि जैवविज्ञान क्षेत्रातील भारतातील सर्वात आघाडीच्या व्हीसी फंड्सपैकी एक असलेल्या एंडीया पार्टनर्सकडून अनामिक रकमेचा निधी उभा केला आहे. या स्टार्टअपला सध्या…
National, 13th January, 2022 (GNI): ‘Gift of Sleep’ is a novel initiative by leading sleep solutions brand, Duroflex to provide uninterrupted restful sleep to underprivileged children as a gift for the New Year. The brand…
Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay100% of test serum samples showed neutralization of the Delta variant and…
Mumbai, 11th January 2022 (GNI): The pandemic transformed people’s homes into their offices as work from home became the norm. Now, it is slowly turning people’s houses into their gyms, as online fitness coaching is…
National, January 10, 2022 (GNI): TATA Medical and Diagnostics Ltd. (TATA MD) has received an order for 5 lakh tests from Odisha State Medical Corporation Limited (OSMCL). The Government of Odisha is the first state in the…
The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events. 6 months after receipt of the second COVAXIN® dose: Durable neutralising, T and B cell responses detected, which suggests good immune memory responses and…